For any questions related to monoclonal antibody infusions you may call (616) 954-1882. Please be aware that you may have to leave a voice message due to the demand being extremely high, but we will do our best to get back to you as soon as possible.
Jump to Section:
Steps to Receive mAB Therapy
1. If you are the patient, call us at (616) 954-1882 to be screened to qualify to receive mAB therapy. NOTE: We are only able to treat patients within 7 days of symptom onset.
2. If you qualify, ask your healthcare provider to fax us a completed order form for your medication, clinical notes, demographics and your insurance card to (616) 818-4484.
3. Providers can find order forms on our medications page.
4. We will then process the order and call you to schedule when/if we have availability. PLEASE NOTE: demand for this therapy is extremely high.
About COVID-19 mAB Therapy
COVID-19 monoclonal antibodies are treatments used for coronavirus disease 2019 (COVID-19). They are investigational medicines used to treat mild to moderate symptoms of COVID-19 in non-hospitalized adults and adolescents (12 years of age and older who weigh at least 88 pounds (40 kg)), and who are at high risk for developing severe COVID-19 symptoms or the need for hospitalization.
COVID-19 monoclonal antibodies are investigational because they are still being studied. There is limited information known about the safety and effectiveness of using these therapies to treat people with COVID-19. The FDA has authorized the emergency use of these medications for the treatment of COVID-19 under an Emergency Use Authorization (EUA).
Frequently Asked Questions
If you test positive for COVID-19, are over 65 years old or have a chronic health condition(s), and are within 10 days of symptom onset you may qualify for COVID-19 mAB therapy. Please call us at (616) 954-1882 to be screened to receive this therapy.
- Hospitalized for COVID-19
- Age <12
- Weight <40kg
- Requiring oxygen for COVID-19
(or increased oxygen requirements due to COVID in a patient who already receives oxygen therapy)